Illumina Inc (ILMN)
122.28
+1.23
(+1.02%)
USD |
NASDAQ |
Apr 26, 16:00
122.28
0.00 (0.00%)
After-Hours: 19:55
Illumina Research and Development Expense (TTM): 1.355B for Dec. 31, 2023
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 1.355B |
September 30, 2023 | 1.36B |
June 30, 2023 | 1.37B |
March 31, 2023 | 1.339B |
December 31, 2022 | 1.321B |
September 30, 2022 | 1.325B |
June 30, 2022 | 1.436B |
March 31, 2022 | 1.311B |
December 31, 2021 | 1.185B |
September 30, 2021 | 1.034B |
June 30, 2021 | 770.00M |
March 31, 2021 | 723.00M |
December 31, 2020 | 682.00M |
September 30, 2020 | 644.00M |
June 30, 2020 | 623.00M |
March 31, 2020 | 634.00M |
December 31, 2019 | 647.00M |
September 30, 2019 | 662.00M |
June 30, 2019 | 670.00M |
March 31, 2019 | 655.00M |
December 31, 2018 | 623.00M |
September 30, 2018 | 584.00M |
June 30, 2018 | 559.00M |
March 31, 2018 | 538.00M |
December 31, 2017 | 546.00M |
Date | Value |
---|---|
September 30, 2017 | 539.00M |
June 30, 2017 | 531.00M |
March 31, 2017 | 526.00M |
December 31, 2016 | 505.00M |
September 30, 2016 | 488.82M |
June 30, 2016 | 462.05M |
March 31, 2016 | 433.23M |
December 31, 2015 | 401.00M |
September 30, 2015 | 430.13M |
June 30, 2015 | 415.98M |
March 31, 2015 | 402.79M |
December 31, 2014 | 388.06M |
September 30, 2014 | 321.84M |
June 30, 2014 | 307.71M |
March 31, 2014 | 292.33M |
December 31, 2013 | 276.74M |
September 30, 2013 | 256.92M |
June 30, 2013 | 240.02M |
March 31, 2013 | 243.64M |
December 31, 2012 | 231.02M |
September 30, 2012 | 219.63M |
June 30, 2012 | 215.97M |
March 31, 2012 | 195.55M |
December 31, 2011 | 196.91M |
September 30, 2011 | 197.20M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
623.00M
Minimum
Jun 2020
1.436B
Maximum
Jun 2022
1.005B
Average
1.034B
Median
Sep 2021
Research and Development Expense (TTM) Benchmarks
Exact Sciences Corp | 425.88M |
Guardant Health Inc | 367.19M |
Mettler-Toledo International Inc | 185.28M |
Natera Inc | 320.68M |
Castle Biosciences Inc | 53.62M |